von Knebel Doeberitz, Philipp L.
De Cecco, Carlo N.
Schoepf, U. Joseph http://orcid.org/0000-0002-6164-5641
Duguay, Taylor M.
Albrecht, Moritz H.
van Assen, Marly
Bauer, Maximilian J.
Savage, Rock H.
Pannell, J. Trent
De Santis, Domenico
Johnson, Addison A.
Varga-Szemes, Akos
Bayer, Richard R.
Schönberg, Stefan O.
Nance, John W.
Tesche, Christian
Article History
Received: 9 August 2018
Revised: 29 September 2018
Accepted: 12 October 2018
First Online: 6 December 2018
Compliance with ethical standards
:
: The scientific guarantor of this publication is U. Joseph Schoepf, MD.
: Dr. Schoepf receives institutional research support from Astellas, Bayer, General Electric, and Siemens Healthineers. Dr. Schoepf has received honoraria for speaking and consulting from Bayer, Guerbet, HeartFlow Inc., and Siemens Healthineers. Dr. De Cecco is a consultant for/receives institutional research support from Bayer and Siemens. Dr. Varga-Szemes receives institutional research support from Siemens Healthineers. The other authors have no conflict of interest to disclose. Workstation-based flow computations of coronary blood flow are not currently approved by the US Food and Drug Administration. A software prototype (Coronary Plaque Analysis 4.2.0 syngo.via FRONTIER, Siemens) was used for the plaque analysis. The concepts and information presented are based on research and are not commercially available.
: One of the authors has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: • Retrospective• Observational study• Performed at one institution